Moody Lynn & Lieberson LLC Sells 2,259 Shares of Danaher Corporation $DHR

Key Points

• Moody Lynn & Lieberson LLC reduced its stake in Danaher Corporation by 37.8%, selling 2,259 shares to hold a total of 3,721 shares, valued at approximately $735,000.
• Director Teri List sold 2,778 shares at an average price of $211.06, reducing her ownership by 11.81% to 20,751 shares.
• Danaher's quarterly revenue increased by 3.4% year-over-year, reporting $5.94 billion in revenue and an EPS of $1.80, exceeding analysts' expectations.

Moody Lynn & Lieberson LLC lessened its stake in Danaher Corporation (NYSE:DHR - Free Report) by 37.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,721 shares of the conglomerate's stock after selling 2,259 shares during the period. Moody Lynn & Lieberson LLC's holdings in Danaher were worth $735,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Hills Bank & Trust Co raised its stake in shares of Danaher by 0.3% in the 1st quarter. Hills Bank & Trust Co now owns 18,015 shares of the conglomerate's stock valued at $3,693,000 after buying an additional 53 shares in the last quarter. Worth Financial Advisory Group LLC raised its position in Danaher by 4.6% in the 2nd quarter. Worth Financial Advisory Group LLC now owns 1,195 shares of the conglomerate's stock valued at $236,000 after purchasing an additional 53 shares during the last quarter. Sageworth Trust Co grew its holdings in shares of Danaher by 2.3% during the first quarter. Sageworth Trust Co now owns 2,404 shares of the conglomerate's stock worth $493,000 after purchasing an additional 54 shares during the last quarter. 1834 Investment Advisors Co. raised its holdings in shares of Danaher by 3.3% in the first quarter. 1834 Investment Advisors Co. now owns 1,666 shares of the conglomerate's stock valued at $342,000 after buying an additional 54 shares during the last quarter. Finally, Bruce G. Allen Investments LLC grew its holdings in Danaher by 13.1% during the 2nd quarter. Bruce G. Allen Investments LLC now owns 467 shares of the conglomerate's stock worth $92,000 after acquiring an additional 54 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Insider Activity

In related news, Director Teri List sold 2,778 shares of the stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares of the company's stock, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 11.20% of the company's stock.

Analyst Ratings Changes

Several research analysts recently weighed in on DHR shares. Royal Bank Of Canada set a $241.00 price objective on shares of Danaher in a research report on Tuesday, September 2nd. Evercore ISI lowered their price objective on Danaher from $230.00 to $226.00 and set an "outperform" rating for the company in a research report on Tuesday, July 8th. Deutsche Bank Aktiengesellschaft dropped their price objective on Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. Guggenheim reaffirmed a "buy" rating and issued a $250.00 target price on shares of Danaher in a research note on Wednesday, July 23rd. Finally, Wells Fargo & Company lowered their price target on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating for the company in a research report on Wednesday, July 23rd. Seventeen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $245.91.

Danaher Trading Up 1.9%

DHR opened at $184.97 on Monday. The firm's fifty day moving average is $199.44 and its two-hundred day moving average is $197.48. The firm has a market cap of $132.45 billion, a PE ratio of 39.36, a price-to-earnings-growth ratio of 2.63 and a beta of 0.75. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $279.59. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The business had revenue of $5.94 billion during the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm's quarterly revenue was up 3.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities research analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Friday, September 26th. Danaher's payout ratio is 27.23%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.